Acquisition adds navtemadlin, a late-stage rare blood cancer asset in Phase III. This hemato-oncology program in myelofibrosis expands Ipsen’s growing Oncology portfolio; Navtem ...
New study identifies CAR3 as a key osteoblast protein promoting collagen mineralization, bone formation, and skeletal ...
BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) gradually strips people of command over their own bodies, advancing steadily with no available cure. More ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results